Skip to main content

Alzheimer's Disease

  • Chapter
Neuroimmune Pharmacology

Historically, the condition of dementia first described by Alois Alzheimer in 1907 was called generically “presenile dementia.” This nomenclature distinguished Alzheimer’s as a disease, and not the dementia that occurred typically as humans reached advanced years, known commonly as “senility.” It was believed that all of us would develop senility after living long enough, and that this was a normal part of the aging process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Morgan, D., Gordon, M.N. (2008). Alzheimer's Disease. In: Gendelman, H.E., Ikezu, T. (eds) Neuroimmune Pharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72573-4_43

Download citation

Publish with us

Policies and ethics